Originally, in Zhang Chen's plan, Canaanite Bacillus would at least wait until the mass spectrometer was mass-produced before providing it to the national military department.

But now it seems that a lot of things are mutual.

The greater the value you show, the more the country values it, and when it is critical, it will support it vigorously.

Just like this time, it was obvious that he didn't know the identity of this old man Wei in advance, but the country still spent a lot of money to hunt him down, just so that he could completely solve this gang of gangsters and protect Zhang Chen.

Zhang Chen made a decision in his heart, and then chatted a few more words.

Human feelings are inevitable, and maybe there will be a time when this director will be used in the future.

Zhang Chen didn't feel that if he had a system, he could ignore everything and be scared.

Of course, it can be done at a certain point, but it certainly can't be done now.

After drinking a few cups of tea, Zhang Chen came to the interrogation room and began to get down to business.

The old man Wei in front of him, even if he was caught, still had a spirit and a natural aura of a superior person.

But after some operation, Zhang Chen felt that his conclusion was too early.

This is a traitor, with his nostrils facing the sky in front of his own people, but in front of the ugly people, he looks low.

This kind of person, Zhang Chen despised very much.

After doing it for a long time, the final mastermind behind the scenes is the ugly elder.

Then wait, there will be a chance to get them later.

After Zhang Chen finished reading Old Man Wei's memory, he deliberately went over and added a clock.

It took 500 points to temporarily strengthen the [EEG analyzer] of the system.

Directly copying the memories of the old man Wei for nearly a year involves the layout of a large number of ugly countries in China.

These evidences are completely enough for Old Man Wei to die more than a dozen times.

There are also many other people and organizations involved, but Zhang Chen does not plan to participate in these anymore.

When he gave this chain of evidence to the director, he laughed wildly, with this information, he could pull out a large number of ugly spies at once.

This is a great credit, the director of the bureau is so good that he wants to take Zhang Chen to eat and drink.

But Zhang Chen politely refused, he had to rush back to Shaocheng today, and if he went to eat again, he was afraid that it would be a little too late in time.

In the next few days, we will devote ourselves to clinical trials.

Seeing that the phase III clinical trial is about to end in a few days.

However, there is still a process to go for the drug to be marketed, not that it can be sold after the end of the phase III clinical trial.

After the completion of the phase III clinical trial, the drug marketing registration application is still required, and it can only be marketed after it is passed.

For drug marketing registration application, it generally takes about one year if the whole process is handled smoothly.

This is a general situation, but Zhang Chen obviously does not belong to the general situation.

Now up and down the country, many people are looking forward to the launch of this drug.

Because the performance of this drug in all aspects is too prominent, if it can go to the last step, it will break some patterns.

Thinkers

Whether it is the preclinical drug safety evaluation or the data results of clinical trials, the performance of Lanyue 001 is impeccable.

Except for the two framed things that appeared in the middle.

But because of these two things, the efficacy of Lanyue 001 is even more prominent.

After no one injected the patient with an unknown drug, the patient's condition immediately stabilized.

It can be seen that the efficacy of Lanyue 001, even with antagonistic drugs, cannot maintain the adverse reactions for a long time.

The General Administration of CDE has long included Lanyue 001 in the green channel, and when the clinical application was approved, it was passed in less than a week.

Zhang Chen estimates that this listing registration application will not take a few days.

September 17th.

Today is the day when the phase III clinical trial of Lanyue 001 ends.

At five o'clock in the afternoon, there was good news from various hospitals, and all the clinical trial data was perfect.

After the end, Zhang Chen immediately organized everyone to sort out the information and prepare the listing registration application.

This time, not only Tian Wenbin and Jiang Lu are two veterans, but also Sun Yue, Huang Ruifang and Liu Qiang, who have recently joined the company, have also helped a lot.

So the progress was very fast, and on the second day, the listing registration application was submitted.

At this moment, everyone breathed a sigh of relief, which means that all everyone's efforts have been condensed in this listing registration application.

Especially Jiang Lu, he excitedly shook hands with Zhang Chen and hugged him.

He knew that this listing application would definitely be approved, and in this way, his greatest wish in his life would be fulfilled.

Fortunately, Chenyue Biotech came to the first place, otherwise he might not have been able to participate in the development of this great drug in this life.

The "greatness" of this medicine is not enough to describe, and for the biopharmaceutical industry, Lanyue 001 is equivalent to a milestone invention.

Its emergence will directly cause a major change in the pharmaceutical industry.

It is foreseeable that there will be fewer and fewer chemical drugs in the future, and when a certain time comes, they will definitely be completely eliminated.

Even a newer generation of protein drugs is expected to be replaced by gene therapy drugs soon.

However, in Jiang Lu's view, this elimination is a matter of course.

If old things are eliminated, it means that the level of science and technology is constantly improving.

And what he didn't know was that this was just the beginning.

And not only in terms of drugs, but also in the near future, the entire biological world will usher in a very radical technological revolution.

And when Zhang Chen has time, other industries have also changed to a greater or lesser extent.

In order to determine the listing time, Zhang Chen also made a special call to the director of the General Administration of CDE.

The last time Li Hanhai came over, Zhang Chen specially left his phone number.

In the end, I got the exact news, saying that it would only take about a week for Lanyue 001 to get the final approval result.

Li Hanhai didn't say anything to death, in a week's time, in fact, he said too much.

Lanyue 001 is a special case in itself, and if you speed up the review of clinical trial data, it is estimated that it will only take two or three days to complete the review directly.

Having got the exact time to go on the market, the top priority now is to quickly set a reasonable price for this drug.

The senior management of Chenyue Biology gathered in the conference room to discuss the price.

Of course, Zhang Chen repeatedly emphasized his wishes, hoping that everyone could afford this medicine.

Throughout the clinical trial, Zhang Chen saw many desperate families.

They were unlucky, but they were lucky to have participated in the clinical trial of Lanyue 001.

After learning their details, Zhang Chen couldn't believe that there was no such miserable family in this world.

The pricing of Lanyue 001 can be moderate, and Zhang Chen didn't expect to earn enough points with this medicine.

This is not possible and unrealistic.

There are many products in the system, as long as they are mass-produced one by one, are you afraid that you will not earn enough points in the future?

In addition, Zhang Chen also has his own plan.

He plans to set the price a little lower at home, and when he exports abroad, the price should be set as high as possible.